Healthcare Noncompete and No-Poach Agreements: Navigating Evolving Federal Regulations and Rapidly Changing State Laws
Potential Impact of Loper Bright and the New Administration
A live 90-minute CLE video webinar with interactive Q&A
This CLE course will guide healthcare counsel on noncompete agreements and other restrictive covenants in healthcare. The panel will provide an update on current federal regulation and evolving state laws for the use of noncompete and no-poach agreements in the healthcare industry taking into account the recent Loper Bright decision and new presidential administration. The panel will also examine the state of the DOJ's no-poach prosecutions and the potential for private litigation. The panel will offer best practices for navigating noncompete and no-poach agreements in healthcare in a rapidly evolving regulatory environment.
Outline
- Restrictive covenants in healthcare: federal regulatory update
- FTC
- NLRB
- Notable state laws
- DOJ no-poach prosecutions
- Private litigation
- Possible impact of Loper Bright and a new administration
- Best practices for noncompete and no-poach agreements in healthcare
Benefits
The panel will review these and other issues:
- What is the current state of federal noncompete regulation? How may this be impacted by the Loper Bright decision and a new administration?
- How are state laws changing generally and as they apply in the healthcare industry?
- What is the status of the DOJ's criminal no-poach prosecutions?
- How can the healthcare industry properly implement restrictive covenants while complying with rapidly changing state and federal laws and administrative guidance?
Faculty
Robert E. Slavkin
Chair, Healthcare Practice Group
Akerman
A former healthcare corporate counsel, compliance, and privacy officer for a publicly traded healthcare company, Mr.... | Read More
A former healthcare corporate counsel, compliance, and privacy officer for a publicly traded healthcare company, Mr. Slavkin represents a variety of clients within the healthcare sector, providing guidance on complex issues and compliance with all appropriate federal and state statutes and regulations. These include federal anti-kickback, Stark laws, Medicare, Medicaid, HIPAA, and FDA regulations, as well as providing guidance on daily operational and compliance issues facing healthcare entities. Mr. Slavkin has significant experience with the Affordable Care Act and the ever-evolving role accountable care plays in U.S. health reform. Maintaining a robust thought leadership presence, he conducts frequent lectures throughout the U.S. on a wide array of healthcare issues, including compliance and development of compliance programs under the federal requirements, HIPAA matters, and other relevant issues.
Closeto be announced.
Early Discount (through 12/20/24)